Looking for top FTSE 100 value shares? Here’s one I’d buy without hesitation

There are still lots of FTSE 100 shares on sale despite the index’s recent gains. Here’s a top pharma stock I think could be too cheap for me to miss.

| More on:
Young female business analyst looking at a graph chart while working from home

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE 100 shares are rocketing again, boosted by hopes over interest rate cuts and fresh weakness in the pound. With 75% of its aggregate earnings coming from abroad, the Footsie receives a boost from a weakening UK currency.

The FTSE 250 has soared in 2024.
Source: London Stock Exchange

London’s premier index is up 6% since the start of 2024. It also continues to print new records on an almost-daily basis. Yet it remains jam-packed with brilliant bargains that could help investors turbocharge their returns.

The wisdom of value investing

Value investing involves picking stocks trading below what they’re worth. The theory is that these shares could deliver market-beating returns once the market wises up to their cheapness and their share prices re-rate.

This is a common occurrence. And it explains why value stocks have historically outperformed growth shares over the long term.

Such outperformance is also because, while growth stocks perform strongly during bull markets, value stocks tend to offer more stability and resilience during market downturns. This reflects the margin of safety their discounts provide which, in turn, limits downside risk.

Investing in value stocks can be risky. Some companies are cheap for a reason due to their high risk profiles, low growth potential, or both.

However, with detailed research and analysis, it’s possible to separate the winners from the losers and make truly spectacular returns.

A top value stock

GSK‘s (LSE:GSK) one top share I’ll be keen to buy at the next opportunity. Concerns over the depth of its drugs pipeline means the pharmaceuticals giant trades at a massive discount to the broader industry.

A discount’s understandable. But I’d argue its size is hard to justify. And especially as the FTSE company’s showing encouraging signs of a turnaround on this front.


Pharma sector P/E ratios. Chart by TradingView

As the chart above shows, GSK’s share price now trades on a forward price-to-earnings (P/E) ratio of 9.6 times. This is far below the corresponding readings for its rivals (in descending order) Eli Lilly, Merck, Pfizer and AstraZeneca.

On top of this, the company’s prospective dividend yield sits at a healthy 3.5%. Only Pfizer, with a yield of 6%, beats GSK here.

Winds of change


GSK’s share price. Chart by TradingView

As I say, GSK’s efforts to boost its product pipeline is really starting to pay off, as first-quarter financials showed last month.

It has had four positive phase III test results so far in 2024 which, in turn, helped its share price gain rebound. And there could be more good news to come.

Analyst Adam Vettese of eToro notes that “[GSK’s] move to focus more heavily on vaccines is proving to be a smart one with several new launches on the pipeline.” He even notes that the business “actually has its nose in front [of AstraZeneca] in terms of performance this year.”

Healthcare stocks like this have enormous growth potential as drugs demand increases. I like it and I think GSK shares might be an attractive way for other investors to capitalise on this opportunity.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc and GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Penny stocks to consider buying while their prices are this cheap

Some of the penny stocks I've been watching have already climbed above the 100p level. But I see potential in…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

Revealed! One of the hottest growth, value, and dividend shares to buy today

This high-dividend, low-cost company is also one of the London stock market's most exciting growth shares, writes Royston Wild.

Read more »

Investing Articles

£20,000 in savings? Here’s how I’d target a £2,219 monthly passive income with FTSE 100 shares

Investing in FTSE 100 shares can be a great way to turn a regular investment into a life-changing passive income…

Read more »

Investing Articles

These are the most popular 2024 Stocks and Shares ISA picks so far

After a few tough years, it looks like the 2024 Stocks and Shares ISA season is getting off to a…

Read more »

Investing Articles

This FTSE 100 ETF may be the simplest way to become a stock market millionaire

Ben McPoland considers one very straightforward stock market investing strategy that could lead to a million-pound portfolio.

Read more »

Investing Articles

I’d buy 11,220 Legal & General shares for £200 a month in passive income

Our writer considers how much money investors would have to put into Legal & General (LON:LGEN) shares to target £2,400…

Read more »

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

These 2 magnificent FTSE 250 shares are on sale right now!

These FTSE 250 companies still look cheap, despite recent share price gains. Here's why our writer Royston Wild thinks they’re…

Read more »

Blue NIO sports car in Oslo showroom
Growth Shares

Down 36% in 2024, how low could NIO shares go?

The electric vehicle sector has seen some tremendous volatility in recent years, but what does the future hold for NIO…

Read more »